DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-08-16

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-08-09

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Trastuzumab
    Dosage: form:vial

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-06-01

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 100 mg, unk
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in female

Reported by a physician from Finland on 2012-04-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Breast Cancer

Capecitabine
    Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
    Administration route: Oral
    Indication: Breast Cancer

Docetaxel
    Dosage: on day 1 as 1-hr intravenous infusion
    Indication: Breast Cancer

Epirubicin
    Dosage: on day 1
    Indication: Breast Cancer

Capecitabine
    Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
    Administration route: Oral

Other drugs received by patient: Corticosteroids



Possible Epirubicin side effects in female

Reported by a physician from Finland on 2012-04-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: on day 1
    Indication: Breast Cancer

Docetaxel
    Dosage: on day 1 as 1-hr intravenous infusion
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: on day 1
    Indication: Breast Cancer

Fluorouracil
    Dosage: on day 1
    Indication: Breast Cancer

Other drugs received by patient: Corticosteroids



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-04-02

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02



Possible Epirubicin side effects in 68 year old female

Reported by a physician from Japan on 2012-03-27

Patient: 68 year old female

Reactions: White Blood Cell Count Decreased, Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017